Neurogene Inc Sustainability Reports
Neurogene Inc. is a clinical-stage biotechnology company focused on developing genetic medicines for rare and devastating neurological diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900A7VIY892SZVW73
FIGI: BBG005Y0QF99
1 reports from 2023 to 2023